1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Chronic Disease Analysis & Statistics in Germany, July 2020

Chronic Disease Analysis & Statistics in Germany, July 2020

1-30 of about 200 reports

Non-cystic Fibrosis Bronchiectasis (NCFB)- Epidemiology Forecast to 2030

  • $ 3750
  • May 2020
  • 100 pages

‘Non-cystic fibrosis bronchiectasis (NCFB) - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Non-cystic fibrosis bronchiectasis epidemiology ...

  • Chronic Disease
  • Cystic Fibrosis
  • Pathology
  • Respiratory Disease
  • Germany

Refractory Angina (RA)- Epidemiology Forecast to 2030

  • $ 3750
  • May 2020
  • 100 pages

‘Refractory Angina (RA) - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Refractory Angina epidemiology in the 7MM, i.e., the United ...

  • Angina
  • Chronic Disease
  • Pathology
  • Germany
  • United States

Familial Hypercholesterolemia - Epidemiology Forecast to 2030

  • $ 3750
  • April 2020
  • 100 pages

‘Familial Hypercholesterolemia (FH) - Epidemiology Forecast–2030’ report delivers an in-depth understanding of the disease, historical and forecasted Familial Hypercholesterolemia (FH) epidemiology ...

  • Cardiovascular Disease
  • Chronic Disease
  • Pathology
  • Germany
  • United States

Chronic Lower Back Pain (CLBP)- Epidemiology Forecast–2030

  • $ 3750
  • April 2020
  • 200 pages

‘Chronic Lower Back Pain (CLBP)- Epidemiology Forecast–2030’ report delivers an in-depth understanding of the Chronic lower back pain (CLBP), historical and forecasted epidemiology as well as the ...

  • Chronic Disease
  • Chronic Pain
  • Pathology
  • Prescription Drug
  • Germany

Diabetic Gastroparesis (DGp)- Epidemiology Forecast-2030

  • $ 3750
  • March 2020
  • 90 pages

‘Diabetic Gastroparesis (DGp)- Epidemiology Forecast-2030’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of DGp in the in 7MM covering the United States, ...

  • Chronic Disease
  • Diabetes
  • Pathology
  • Germany
  • United Kingdom

Succeeding in the 2020 Europe Respiratory Diseases Diagnostic Market for 8 Tests: France, Germany, Italy, Spain, UK

  • $ 5500
  • February 2020
  • 335 pages

Succeeding in the 2020 Europe Respiratory Diseases Diagnostic Market for 8 Tests: France, Germany, Italy, Spain, UK This new 335-page report provides analysis of the European respiratory disease testing ...

  • Chronic Disease
  • Pathology
  • Respiratory Disease
  • Europe
  • Germany

Type 2 Diabetes: Epidemiology Forecast to 2028

  • $ 3995
  • January 2020
  • 50 pages

Type 2 Diabetes: Epidemiology Forecast to 2028 Summary Type 2 diabetes (T2D), formerly known as non-insulin-dependent diabetes mellitus or adult-onset diabetes mellitus, is a chronic disorder of glucose ...

  • Chronic Disease
  • Type 2 Diabetes
  • Germany
  • World
  • Forecast

Systemic Lupus Erythematosus and Lupus Nephritis: Epidemiology Forecast to 2028

  • $ 3995
  • January 2020
  • 57 pages

Systemic Lupus Erythematosus and Lupus Nephritis: Epidemiology Forecast to 2028 Summary Systemic lupus erythematosus (SLE) is a chronic autoimmune disease of multifactorial origin that can affect any ...

  • Chronic Disease
  • Musculoskeletal Disorder
  • Germany
  • United States
  • Forecast

Protagen AG - Product Pipeline Analysis, 2019 Update

  • $ 750
  • December 2019
  • 42 pages

Summary Protagen AG (Protagen) is a medical device company that develops molecular diagnostic and companion diagnostic test equipment.The company’s products include multilisa SSC, multilisa SLE and multilisa ...

  • Chronic Disease
  • Mental Health
  • Pathology
  • Germany
  • Protagen AG

Birch Pollen Allergy - Pipeline Review, H2 2019

  • $ 2000
  • August 2019
  • 37 pages

Birch Pollen Allergy - Pipeline Review, H2 2019 Summary The latest Pharmaceutical and Healthcare disease pipeline guide Birch Pollen Allergy - Pipeline Review, H2 2019, provides an overview of the Birch ...

  • Chronic Disease
  • Immunotherapy
  • Germany
  • Product Initiative
  • Anergis SA

Germany Respiratory Diseases Diagnostic Testing Market, 2019-2023: Supplier Shares by Test, Volume and Sales Segment Forecasts, Competitive Analysis, Emerging Technologies, Instrumentation Review, Opportunities for Suppliers

  • $ 1250
  • July 2019
  • 283 pages

Germany Respiratory Diseases Diagnostic Testing Market, 2019-2023: Supplier Shares by Test, Volume and Sales Segment Forecasts, Competitive Analysis, Emerging Technologies, Instrumentation Review, Opportunities ...

  • Chronic Disease
  • Medical Biotechnology
  • Germany
  • Demand
  • Forecast

Germany Diabetes Market Report: 2019 - 2024

  • $ 1999
  • June 2019
  • 92 pages

the analyst’s new report “Germany Diabetes Market Report: 2019 - 2024” provides an analytical and statistical insight into the Germany diabetes market. The report provides both current and future ...

  • Chronic Disease
  • Diabetes
  • Pathology
  • Germany
  • Market Size

2019 Germany Respiratory Diseases Diagnostic Testing Market: Supplier Shares by Test, Volume and Sales Segment Forecasts, Competitive Analysis, Emerging Technologies, Instrumentation Review, Opportunities for Suppliers

  • $ 1850
  • April 2019
  • 283 pages

2019 Germany Respiratory Diseases Diagnostic Testing Market: Supplier Shares by Test, Volume and Sales Segment Forecasts, Competitive Analysis, Emerging Technologies, Instrumentation Review, Opportunities ...

  • Chronic Disease
  • Infectious Disease
  • Germany
  • Demand
  • Forecast

2019-2023 Competing in the Germany Respiratory Diseases Diagnostic Testing Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

  • $ 1950
  • March 2019
  • 283 pages

2019-2023 Competing in the Germany Respiratory Diseases Diagnostic Testing Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation ...

  • Chronic Disease
  • Infectious Disease
  • Germany
  • Demand
  • Forecast

OMEICOS Therapeutics GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • November 2018
  • 28 pages

Summary OMEICOS Therapeutics GmbH (OMEICOS) is a biopharmaceutical company that develops small molecule therapeutics for the prevention and treatment of cardiovascular and ophthalmic diseases.The company ...

  • Chronic Disease
  • Therapy
  • Germany
  • Company
  • OMEICOS Therapeutics GmbH

Boehringer Ingelheim GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile, GlobalData

  • $ 250
  • October 2018
  • 154 pages

Summary Boehringer Ingelheim GmbH (Boehringer), a subsidiary of CH Boehringer Sohn AG & Co KG is a pharmaceutical company that conducts research, development, manufacture and sale of pharmaceuticals.It ...

  • Chronic Disease
  • Pharmaceutical
  • Therapy
  • Germany
  • Boehringer Ingelheim GmbH

Germany Remote Patient Monitoring Device Market Size, Forecast And Trend Analysis, 2014 - 2025

  • $ 1950
  • July 2018
  • 100 pages

Germany Remote Patient Monitoring Device Market Size and Forecast by Product (Vital Sign Monitors, Specialized Monitors), by Application, by End Use And Trend Analysis, 2014 - 2025 The Germany remote ...

  • Chronic Disease
  • Patient Monitoring
  • Germany
  • United States
  • Demand

Probiogen AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • July 2018
  • 103 pages

Probiogen AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline’s Probiogen AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report ...

  • Cardiology
  • Chronic Disease
  • Pharmaceutical
  • Germany
  • ProBioGen AG

Bayer Healthcare Pharmaceuticals - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • July 2018
  • 268 pages

Bayer Healthcare Pharmaceuticals - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline’s Bayer Healthcare Pharmaceuticals Mergers & Acquisitions (M&A), Partnerships ...

  • Chronic Disease
  • Hospital
  • Germany
  • Company
  • Bayer AG

Protagen AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • July 2018
  • 87 pages

Protagen AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline’s Protagen AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report ...

  • Chronic Disease
  • Healthcare
  • Immunology
  • Germany
  • Protagen AG

Immatics Biotechnologies GmbH - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • July 2018
  • 76 pages

Immatics Biotechnologies GmbH - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline’s Immatics Biotechnologies GmbH Mergers & Acquisitions (M&A), Partnerships ...

  • Chronic Disease
  • Healthcare
  • Germany
  • Corporate Finance
  • Immatics Biotechnologies GmbH

Bayer CropScience AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • July 2018
  • 280 pages

Bayer CropScience AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline’s Bayer CropScience AG Mergers & Acquisitions (M&A), Partnerships & Alliances and ...

  • Chronic Disease
  • Pharmaceutical
  • Germany
  • M&A
  • Bayer AG

Merz Pharma GmbH & Co. KGaA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • July 2018
  • 276 pages

Merz Pharma GmbH & Co. KGaA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline’s Merz Pharma GmbH & Co. KGaA Mergers & Acquisitions (M&A), Partnerships ...

  • Chronic Disease
  • Healthcare
  • Pharmaceutical
  • Germany
  • Merz Pharmaceuticals GmbH

Bayer AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • July 2018
  • 681 pages

Bayer AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline’s Bayer AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes ...

  • Chronic Disease
  • Healthcare
  • Pharmaceutical
  • Therapy
  • Germany

Illumina, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • July 2018
  • 115 pages

Illumina, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline’s Illumina, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments ...

  • Cancer
  • Chronic Disease
  • Germany
  • Corporate Finance
  • Illumina, Inc.

Europe Insulin Pump Market, Users, Reimbursement Policy, Countries (Germany, France, Netherlands, Switzerland, Sweden, and UK) Clinical Trials and Training Model Analysis

  • $ 1790
  • July 2018
  • 130 pages

Europe insulin pump market is projected to be more than US$ 2.4 Billion by the end of year 2024. The numbers of factors contributing to the growth of insulin pump in Europe are growing ageing population, ...

  • Chronic Disease
  • Diabetes
  • Insulin Delivery
  • Medical Device
  • Germany

2018 Germany Respiratory Diseases Diagnostic Testing Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

  • $ 1250
  • June 2018
  • 283 pages

About This ReportThis new 283-page report .com presents detailed analysis of the German Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, ...

  • Chronic Disease
  • Infectious Disease
  • Germany
  • Demand
  • Forecast

Europe Blood Glucose Device Market, Forecast SMBG Components (Test Strips, Lancet, Meter), Diabetes Population (Type 1 & 2)

  • $ 1290
  • April 2018
  • 183 pages

Self-Monitoring Blood Glucose (SMBG) device market is providing big business opportunities for device manufactures in the Europe. It is projected that Europe Blood Glucose Device market will climb to nearly ...

  • Chronic Disease
  • Diabetes
  • Germany
  • Scandinavia
  • Forecast

Osteoporosis: Epidemiology Forecast to 2027

  • $ 3995
  • April 2018
  • 41 pages

Osteoporosis: Epidemiology Forecast to 2027 Summary Osteoporosis is a disease in which the density and quality of bone are reduced over time.In a normal process known as remodeling, some of a person’s ...

  • Chronic Disease
  • Musculoskeletal Disorder
  • Germany
  • Japan
  • Forecast

EpiCast Report: Chronic Kidney Disease - Epidemiology Forecast to 2026

  • $ 3995
  • December 2017
  • 32 pages

EpiCast Report: Chronic Kidney Disease - Epidemiology Forecast to 2026 Summary Chronic kidney disease (CKD), or chronic renal disease, is an asymptomatic, long-term condition that damages the kidneys ...

  • Chronic Disease
  • Renal Disease
  • Germany
  • United States
  • Forecast
29 reports

Download Unlimited Documents from Trusted Public Sources

View report >

Healthcare Industry - Investor Report, October 2018

  • October 2018
  • 29 pages
  • Chronic Disease
  • Germany
  • United States
  • Company
  • Demand

OTC Markets October 2015

Demographic Analysis January 2013


Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on